These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5376219)

  • 1. [In vivo studies on multiple-step cancer therapy using immune antibodies for attack induction. Variant for metastasis treatment].
    von Ardenne M; Chaplain RA; Prokop O
    Dtsch Gesundheitsw; 1969 Aug; 24(34):1589-93. PubMed ID: 5376219
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro studies on the induction of an immunochemical attack using anti-AHP in the scope of cancer multiple-step therapy].
    von Ardenne M; Krüger W; Prokop O; Schnitzler S
    Dtsch Gesundheitsw; 1969 Mar; 24(13):588-94. PubMed ID: 4913012
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vivo studies on cancer multiple-step therapy using the attack combination of optimum tumor overacidification, hyperthermia and weak X-irradiation].
    von Ardenne M; Chaplain RA; Reitnauer PG
    Dtsch Gesundheitsw; 1969 May; 24(20):924-35. PubMed ID: 5375903
    [No Abstract]   [Full Text] [Related]  

  • 4. [Theoretical observations on the optimization of the "weakening" attack within the scope of multiple-step therapy of cancer. Pharmacokinetic principle for the selective transport of cytotoxin into cancer tissue].
    von Ardenne M; Reitnauer PG
    Z Arztl Fortbild (Jena); 1969 Sep; 63(18):965-70. PubMed ID: 5362211
    [No Abstract]   [Full Text] [Related]  

  • 5. [Migration capacity of tumor cells treated with immune sera].
    Lebedev KA; Kaulen DR; Khorobrykh VV; D'iakov GN; Simonova AV
    Biull Eksp Biol Med; 1977 Dec; 84(12):712-4. PubMed ID: 597608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of the growth of Ehrlich transplantable carcinoma in mice by antichorionic immune serum].
    Dil'man VM; Tsyrlina EV; Bulovskaia LN; Bobrov IuF
    Vopr Onkol; 1983; 29(2):62-4. PubMed ID: 6836972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of in vivo antitumour activity of xenogeneic antiserum by autotransplanted normal spleen cells in mice.
    Jakóbisiak M; Kańtoch M; Lasek W; Rozmysłowicz T; Obłakowski P; Dobaczewska H
    Eur J Cancer (1965); 1981 Jan; 17(1):77-80. PubMed ID: 7262149
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent leukocytes.
    Dobaczewska H
    Neoplasma; 1982; 29(3):323-5. PubMed ID: 7133227
    [No Abstract]   [Full Text] [Related]  

  • 9. [Different immunological factors in the therapy of an experimental tumor].
    Nicolin A; Frontini E; Olivani P
    Boll Ist Sieroter Milan; 1971; 50(4):295-8. PubMed ID: 5163498
    [No Abstract]   [Full Text] [Related]  

  • 10. A vaccine and immune serum for ascites tumor of mice and therapy of skin tumors.
    Ryu E
    Dev Biol Stand; 1977 Apr 13-15; 38():381-5. PubMed ID: 608527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of ascites tumour with cytolytic serum obtained by double immunization.
    Mihaescu GH; Micu N; Popp I; Comisel V; Mihaescu I
    Neoplasma; 1974; 21(3):297-302. PubMed ID: 4424781
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM.
    Saha S; Mondal S
    Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of various means of administering antitumor serum on the mitotic activity and DNA concentration of tumor cells].
    Sukhorukikh SV
    Biull Eksp Biol Med; 1968 Sep; 66(9):81-3. PubMed ID: 5758914
    [No Abstract]   [Full Text] [Related]  

  • 14. [Overacidification limit and pH of tumor cells in relation to multi-step cancer therapy].
    von Ardenne M; Reitnauer PG
    Acta Biol Med Ger; 1970; 25(3):483-93. PubMed ID: 5523115
    [No Abstract]   [Full Text] [Related]  

  • 15. Passive immunotherapy of mice bearing Ehrlich ascites tumor expressing human, membrane-bound placental alkaline phosphatase.
    Barka T; Henderson S; van der Noen HM
    Tumour Biol; 2000; 21(3):145-52. PubMed ID: 10754465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Ehrlich subcutaneous solid tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype antibody.
    Saha S; Mondal S
    J Exp Clin Cancer Res; 2001 Mar; 20(1):75-84. PubMed ID: 11370834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of virus inhibitory factor or interferon in the antitumoral effect of whole-body hyperthermia].
    Nakamura W; Nagano Y; Otsuka K; Nishimoto Y
    C R Seances Soc Biol Fil; 1980; 174(1):104-7. PubMed ID: 6160896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of serum humoral factors in metastasis and recurrence of Ehrlich carcinoma in mice].
    Donenko FV; Sitdikova SM; Moroz LV
    Biull Eksp Biol Med; 1997 Oct; 124(10):443-5. PubMed ID: 9410180
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of passively administered antibodies on the development of Ehrlich tumor in mice].
    Strzelecka G
    Ann Acad Med Stetin; 1980; 26():387-400. PubMed ID: 7186780
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific and non-specific immunotherapy of Ehrlich Ascites Carcinoma in mice.
    Jakóbisiak M; Kańtoch M; Lasek W; Dobaczewska H; Obłakowski P
    Folia Biol (Krakow); 1982; 30(3-4):91-7. PubMed ID: 7166197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.